Overview Payan v. Los Angeles Community College District (U.S. Court of Appeals, 9th Circuit, Aug. 24, 2021): Plaintiffs, including a nonprofit advocacy group and students…
Overview Doe v. San Diego Unified School District (U.S. Court of Appeals, 9th Cir., Dec. 4, 2021): A high school student challenged San Diego Unified…
Overview Hawse v. Page (U.S. Court of Appeals, 8th Circuit, July 30, 2021): Plaintiffs, church members in Saint Louis County, Missouri, challenged a public health…
This guidance provides responses to questions related to whether healthcare providers may prescribe off-label uses of COVID-19 vaccines that have received Emergency Use Authorization but have not yet received a biologics license or other approval from FDA.
Overview Cargill v. Garland (U.S. Court of Appeals, 5th Cir., Dec. 14, 2021): The 5th Circuit affirmed a lower court decision upholding the federal Bureau…
This report updates and expands on the initial rapid COVID-19 legal assessment published in August 2020 and offers policy recommendations on 35 wide-ranging topics, from pandemic preparedness and expanding health care to conducting sound elections and adapting immigration policy.
Overview Valdez v. Grisham (U.S. District Court, D.N.M., Sept. 13, 2021): Plaintiffs, a healthcare worker and an individual wishing to participate in the New Mexico…
Overview Guns Save Life, Inc. v. Ali (Supreme Court of Illinois, Oct. 21, 2021): The Supreme Court of Illinois held that Cook County’s firearm and…
The following guidance document can help guide stakeholders in developing and implementing declarations as well as thinking through broader issues connected to race and racism.
Overview The Health Insurance Portability and Accountability Act of 1996, Public Law 104-191 (HIPAA), covers most health departments at the state and local levels. This…
Overview Center for Community Action & Environmental Justice v. Federal Aviation Administration (U.S. Court of Appeals, 9th Cir., Nov. 18, 2021): The 9th Circuit upheld…
Drug overdose continues to claim the lives of tens of thousands of people in the U.S. every year. Opioids, both prescription painkillers and street drugs such as heroin and illicitly manufactured fentanyl, are responsible for the majority of these deaths. In response, states have passed legislation to increase access to the opioid overdose reversal medication naloxone, including provisions that allow for the distribution of naloxone through pharmacies. Some states have gone further and now require that naloxone be prescribed or offered to some patients. This fact sheet describes those requirements and links to the relevant laws.
